Continuous glucose monitoring (CGM) represents one of the most commercially robust sectors within medical technology, transitioning diabetes management from episodic capillary blood testing to continuous, actionable glycemic trend analysis. Despite widespread adoption among insulin-dependent populations, conventional CGM systems remain tethered to subcutaneous filament architectures that penetrate several millimeters into the skin, introducing tissue trauma, biofouling and ma

The acquisition represents a decisive structural consolidation within the global digital imaging components sector. Varex, headquartered in Salt Lake City, Utah, employs approximately 2,400 people across operations in North America, Europe, and Asia. The company maintains a decades-long heritage in designing and manufacturing high-specification X-ray sources, flat-panel digital detectors, photon-counting detectors, high-voltage interconnects and imaging software.